| Drug Name: | Formoterol (73573-87-2) |
|---|---|
| PubChem ID: | 3410 |
| SMILES: | CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O |
| InchiKey: | BPZSYCZIITTYBL-UHFFFAOYSA-N |
| Therapeutic Category: | Adrenergic Agents, Adrenergic Agonists, Adrenergic beta-2 Receptor Agonists, Adrenergic beta-Agonists, Anti-Asthmatic Agents, Autonomic Agents, Bronchodilator Agents, Neurotransmitter Agents, Peripheral Nervous System Agents, Respiratory System Agents |
| Molecular Weight (dalton) | : | 344.411 |
| LogP | : | 2.2233 |
| Ring Count | : | 2 |
| Hydrogen Bond Acceptor Count | : | 5 |
| Hydrogen Bond Donor Count | : | 4 |
| Total Polar Surface Area | : | 90.82 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|---|---|---|
| Desensitization Cardiovascular Effects | Beta-2 adrenergic receptor (P07550) | Bronchodilatation@ susceptibility to agonist-induced desensitization@cardiovascular effects. [ ADR Type 1 ] | Beta2-adrenergic receptor genetics |
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category